BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 34997451)

  • 21. Landscape of Genomic Alterations in
    Yan Y; Takayasu T; Hines G; Dono A; Hsu SH; Zhu JJ; Riascos-Castaneda RF; Kamali A; Bhattacharjee MB; Blanco AI; Tandon N; Kim DH; Ballester LY; Esquenazi AY
    JCO Precis Oncol; 2020 Nov; 4():575-584. PubMed ID: 35050747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of
    Dono A; Ramesh AV; Wang E; Shah M; Tandon N; Ballester LY; Esquenazi Y
    Neurooncol Adv; 2021; 3(1):vdab050. PubMed ID: 34131647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
    Dono A; Mitra S; Shah M; Takayasu T; Zhu JJ; Tandon N; Patel CB; Esquenazi Y; Ballester LY
    J Neurooncol; 2021 May; 153(1):153-160. PubMed ID: 33881725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.
    Jackson C; Choi J; Khalafallah AM; Price C; Bettegowda C; Lim M; Gallia G; Weingart J; Brem H; Mukherjee D
    J Neurooncol; 2020 Jul; 148(3):419-431. PubMed ID: 32562247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characteristics and clinical features of multifocal glioblastoma.
    Dono A; Wang E; Lopez-Rivera V; Ramesh AV; Tandon N; Ballester LY; Esquenazi Y
    J Neurooncol; 2020 Jun; 148(2):389-397. PubMed ID: 32440969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.
    Wen PY; Weller M; Lee EQ; Alexander BM; Barnholtz-Sloan JS; Barthel FP; Batchelor TT; Bindra RS; Chang SM; Chiocca EA; Cloughesy TF; DeGroot JF; Galanis E; Gilbert MR; Hegi ME; Horbinski C; Huang RY; Lassman AB; Le Rhun E; Lim M; Mehta MP; Mellinghoff IK; Minniti G; Nathanson D; Platten M; Preusser M; Roth P; Sanson M; Schiff D; Short SC; Taphoorn MJB; Tonn JC; Tsang J; Verhaak RGW; von Deimling A; Wick W; Zadeh G; Reardon DA; Aldape KD; van den Bent MJ
    Neuro Oncol; 2020 Aug; 22(8):1073-1113. PubMed ID: 32328653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma.
    Molinaro AM; Hervey-Jumper S; Morshed RA; Young J; Han SJ; Chunduru P; Zhang Y; Phillips JJ; Shai A; Lafontaine M; Crane J; Chandra A; Flanigan P; Jahangiri A; Cioffi G; Ostrom Q; Anderson JE; Badve C; Barnholtz-Sloan J; Sloan AE; Erickson BJ; Decker PA; Kosel ML; LaChance D; Eckel-Passow J; Jenkins R; Villanueva-Meyer J; Rice T; Wrensch M; Wiencke JK; Oberheim Bush NA; Taylor J; Butowski N; Prados M; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Berger MS
    JAMA Oncol; 2020 Apr; 6(4):495-503. PubMed ID: 32027343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas.
    Brat DJ; Aldape K; Colman H; Figrarella-Branger D; Fuller GN; Giannini C; Holland EC; Jenkins RB; Kleinschmidt-DeMasters B; Komori T; Kros JM; Louis DN; McLean C; Perry A; Reifenberger G; Sarkar C; Stupp R; van den Bent MJ; von Deimling A; Weller M
    Acta Neuropathol; 2020 Mar; 139(3):603-608. PubMed ID: 31996992
    [No Abstract]   [Full Text] [Related]  

  • 29. Longitudinal molecular trajectories of diffuse glioma in adults.
    Barthel FP; Johnson KC; Varn FS; Moskalik AD; Tanner G; Kocakavuk E; Anderson KJ; Abiola O; Aldape K; Alfaro KD; Alpar D; Amin SB; Ashley DM; Bandopadhayay P; Barnholtz-Sloan JS; Beroukhim R; Bock C; Brastianos PK; Brat DJ; Brodbelt AR; Bruns AF; Bulsara KR; Chakrabarty A; Chakravarti A; Chuang JH; Claus EB; Cochran EJ; Connelly J; Costello JF; Finocchiaro G; Fletcher MN; French PJ; Gan HK; Gilbert MR; Gould PV; Grimmer MR; Iavarone A; Ismail A; Jenkinson MD; Khasraw M; Kim H; Kouwenhoven MCM; LaViolette PS; Li M; Lichter P; Ligon KL; Lowman AK; Malta TM; Mazor T; McDonald KL; Molinaro AM; Nam DH; Nayyar N; Ng HK; Ngan CY; Niclou SP; Niers JM; Noushmehr H; Noorbakhsh J; Ormond DR; Park CK; Poisson LM; Rabadan R; Radlwimmer B; Rao G; Reifenberger G; Sa JK; Schuster M; Shaw BL; Short SC; Smitt PAS; Sloan AE; Smits M; Suzuki H; Tabatabai G; Van Meir EG; Watts C; Weller M; Wesseling P; Westerman BA; Widhalm G; Woehrer A; Yung WKA; Zadeh G; Huse JT; De Groot JF; Stead LF; Verhaak RGW;
    Nature; 2019 Dec; 576(7785):112-120. PubMed ID: 31748746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Craniotomy for recurrent glioblastoma: Is it justified? A comparative cohort study with outcomes over 10 years.
    Mukherjee S; Wood J; Liaquat I; Stapleton SR; Martin AJ
    Clin Neurol Neurosurg; 2020 Jan; 188():105568. PubMed ID: 31739155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016.
    Ostrom QT; Cioffi G; Gittleman H; Patil N; Waite K; Kruchko C; Barnholtz-Sloan JS
    Neuro Oncol; 2019 Nov; 21(Suppl 5):v1-v100. PubMed ID: 31675094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
    Neftel C; Laffy J; Filbin MG; Hara T; Shore ME; Rahme GJ; Richman AR; Silverbush D; Shaw ML; Hebert CM; Dewitt J; Gritsch S; Perez EM; Gonzalez Castro LN; Lan X; Druck N; Rodman C; Dionne D; Kaplan A; Bertalan MS; Small J; Pelton K; Becker S; Bonal D; Nguyen QD; Servis RL; Fung JM; Mylvaganam R; Mayr L; Gojo J; Haberler C; Geyeregger R; Czech T; Slavc I; Nahed BV; Curry WT; Carter BS; Wakimoto H; Brastianos PK; Batchelor TT; Stemmer-Rachamimov A; Martinez-Lage M; Frosch MP; Stamenkovic I; Riggi N; Rheinbay E; Monje M; Rozenblatt-Rosen O; Cahill DP; Patel AP; Hunter T; Verma IM; Ligon KL; Louis DN; Regev A; Bernstein BE; Tirosh I; Suvà ML
    Cell; 2019 Aug; 178(4):835-849.e21. PubMed ID: 31327527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Radiation Necrosis: Incidence, Pathogenesis, Diagnostic Challenges, and Future Opportunities.
    Ali FS; Arevalo O; Zorofchian S; Patrizz A; Riascos R; Tandon N; Blanco A; Ballester LY; Esquenazi Y
    Curr Oncol Rep; 2019 Jun; 21(8):66. PubMed ID: 31218455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Meta-Analysis of Survival Outcomes Following Reoperation in Recurrent Glioblastoma: Time to Consider the Timing of Reoperation.
    Zhao YH; Wang ZF; Pan ZY; Péus D; Delgado-Fernandez J; Pallud J; Li ZQ
    Front Neurol; 2019; 10():286. PubMed ID: 30984099
    [No Abstract]   [Full Text] [Related]  

  • 35. The Role of Standard and Advanced Imaging for the Management of Brain Malignancies From a Radiation Oncology Standpoint.
    Press RH; Zhong J; Gurbani SS; Weinberg BD; Eaton BR; Shim H; Shu HG
    Neurosurgery; 2019 Aug; 85(2):165-179. PubMed ID: 30535032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. cIMPACT-NOW update 3: recommended diagnostic criteria for "Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV".
    Brat DJ; Aldape K; Colman H; Holland EC; Louis DN; Jenkins RB; Kleinschmidt-DeMasters BK; Perry A; Reifenberger G; Stupp R; von Deimling A; Weller M
    Acta Neuropathol; 2018 Nov; 136(5):805-810. PubMed ID: 30259105
    [No Abstract]   [Full Text] [Related]  

  • 37. National Trends for Reoperation in Older Patients with Glioblastoma.
    Chen YR; Sole J; Ugiliweneza B; Johnson E; Burton E; Woo SY; Koutourousiou M; Williams B; Boakye M; Skirboll S
    World Neurosurg; 2018 May; 113():e179-e189. PubMed ID: 29427817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relationship between repeat resection and overall survival in patients with glioblastoma: a time-dependent analysis.
    Goldman DA; Hovinga K; Reiner AS; Esquenazi Y; Tabar V; Panageas KS
    J Neurosurg; 2018 Nov; 129(5):1231-1239. PubMed ID: 29303449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.
    Wann A; Tully PA; Barnes EH; Lwin Z; Jeffree R; Drummond KJ; Gan H; Khasraw M
    J Neurooncol; 2018 Apr; 137(2):409-415. PubMed ID: 29294233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of Reintervention in Recurrent Glioblastoma: An Indispensable Weapon for Increasing Survival.
    Delgado-Fernandez J; Garcia-Pallero MÁ; Blasco G; Penanes JR; Gil-Simoes R; Pulido P; Sola RG
    World Neurosurg; 2017 Dec; 108():610-617. PubMed ID: 28939537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.